Jerónimo C - Search Results

1

Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer.

Jin Y, Qu S, Tesikova M, Wang L, Kristian A, Mælandsmo GM, Kong H, Zhang T, Jerónimo C, Teixeira MR, Yuca E, Tekedereli I, Gorgulu K, Alpay N, Sood AK, Lopez-Berestein G, Danielsen HE, Ozpolat B, Saatcioglu F. Jin Y, et al. Among authors: jeronimo c. Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):E2572-81. doi: 10.1073/pnas.1304318110. Epub 2013 Jun 24. Proc Natl Acad Sci U S A. 2013. PMID: 23798432 Free PMC article.

2

Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.

Henrique R, Jerónimo C, Hoque MO, Carvalho AL, Oliveira J, Teixeira MR, Lopes C, Sidransky D. Henrique R, et al. Among authors: jeronimo c. DNA Cell Biol. 2005 Apr;24(4):264-9. doi: 10.1089/dna.2005.24.264. DNA Cell Biol. 2005. PMID: 15812243

3

Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients.

Ribeiro FR, Henrique R, Martins AT, Jerónimo C, Teixeira MR. Ribeiro FR, et al. Among authors: jeronimo c. Eur Urol. 2007 Jul;52(1):116-25. doi: 10.1016/j.eururo.2006.09.018. Epub 2006 Oct 10. Eur Urol. 2007. PMID: 17070983

4

Epigenetic regulation of Wnt signaling pathway in urological cancer.

Costa VL, Henrique R, Ribeiro FR, Carvalho JR, Oliveira J, Lobo F, Teixeira MR, Jerónimo C. Costa VL, et al. Among authors: jeronimo c. Epigenetics. 2010 May 16;5(4):343-51. doi: 10.4161/epi.5.4.11749. Epub 2010 May 10. Epigenetics. 2010. PMID: 20421722

5

Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer.

Carvalho JR, Filipe L, Costa VL, Ribeiro FR, Martins AT, Teixeira MR, Jerónimo C, Henrique R. Carvalho JR, et al. Among authors: jeronimo c. Apoptosis. 2010 Aug;15(8):956-65. doi: 10.1007/s10495-010-0508-6. Apoptosis. 2010. PMID: 20464497

6

Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements.

Santos J, Mesquita D, Barros-Silva JD, Jerónimo C, Henrique R, Morais A, Paulo P, Teixeira MR. Santos J, et al. Among authors: jeronimo c. Oncoscience. 2015 Mar 17;2(5):497-507. doi: 10.18632/oncoscience.142. eCollection 2015. Oncoscience. 2015. PMID: 26097883 Free PMC article.

7

Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker.

Jerónimo C, Henrique R, Hoque MO, Ribeiro FR, Oliveira J, Fonseca D, Teixeira MR, Lopes C, Sidransky D. Jerónimo C, et al. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4010-4. doi: 10.1158/1078-0432.CCR-03-0643. Clin Cancer Res. 2004. PMID: 15217932

8

Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer.

Jerónimo C, Henrique R, Oliveira J, Lobo F, Pais I, Teixeira MR, Lopes C. Jerónimo C, et al. J Clin Pathol. 2004 Aug;57(8):872-6. doi: 10.1136/jcp.2003.014555. J Clin Pathol. 2004. PMID: 15280411 Free PMC article.

9

A quantitative promoter methylation profile of prostate cancer.

Jerónimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, Oliveira J, Teixeira MR, Lopes C, Sidransky D. Jerónimo C, et al. Clin Cancer Res. 2004 Dec 15;10(24):8472-8. doi: 10.1158/1078-0432.CCR-04-0894. Clin Cancer Res. 2004. PMID: 15623627

10

MT1G hypermethylation is associated with higher tumor stage in prostate cancer.

Henrique R, Jerónimo C, Hoque MO, Nomoto S, Carvalho AL, Costa VL, Oliveira J, Teixeira MR, Lopes C, Sidransky D. Henrique R, et al. Among authors: jeronimo c. Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1274-8. doi: 10.1158/1055-9965.EPI-04-0659. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15894685

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

355 results

Search Page